Early Access — free while we kick the tires
EdgarHawk

Diyong Xu

Director

Director 10% Owner

Latest: Director buying · May 2026

1 filing analyzed · 1 company · Latest 2026-06-01

Never miss a filing from Diyong Xu

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Q32 Bio Inc. QTTB 1 0 Net buying

Activity

June 2026
2026-06-01 Q32 Bio Inc. QTTB
medium
Buy
1,875,000 shares
$15,000,000
Significance 6/10

Director Diyong Xu acquired 1,875,000 shares for $15,000,000.00 at $8.00 via 2 transactions in private placement deal

Director Diyong Xu completed two separate purchases totaling 1,875,000 shares for $15,000,000.00 at $8.00 per share on 2026-05-28. The filing is flagged as a private placement, PIPE, registered direct, or IPO allocation—not a discretionary open-market purchase, so this transaction does not reflect independent insider conviction. The current stock price of $11.66 stands 11.3% below the 52-week high of $13.15, and the company reported zero revenue in the latest quarter with net income of -$7,609,000.00. The acquisition is noteworthy as a significant capital commitment ($15.0M) by a director during structured financing, but investors should distinguish this from voluntary open-market accumulation.

Related insiders